Compositions and methods for pairwise sequencing

Patent metadata

Field	Value
Publication number	US-11859241-B2
Application number	US-202318166429-A
Country	US
Kind code	B2
Filing date	Feb 8, 2023
Priority date	Jun 17, 2021
Publication date	Jan 2, 2024
Grant date	Jan 2, 2024

Abstract

The present disclosure provides compositions and methods that employ the compositions for conducting pairwise sequencing and for generating concatemer template molecules for pairwise sequencing. The concatemers can be generated using a rolling circle amplification reaction which is conducted either on-support, or conducted in-solution and then distributed onto a support. The rolling circle amplification reaction generates concatemers containing tandem copies of a sequence of interest and at least one universal adaptor sequence. An increase in the number of tandem copies in a given concatemer increases the number of sites along the concatemer for hybridizing to multiple sequencing primers which serve as multiple initiation sites for polymerase-catalyzed sequencing reactions. When the sequencing reaction employs detectably labeled nucleotides and/or detectably labeled multivalent molecules (e.g., having nucleotide units), the signals emitted by the nucleotides or nucleotide units that participate in the parallel sequencing reactions along the concatemer yields an increased signal intensity for each concatemer.

First claim

The invention claimed is:

1. A method for pairwise sequencing, comprising:
a) providing a plurality of immobilized nucleic acid concatemer template molecules each comprising at least one uridine that can be enzymatically cleaved to generate an abasic site in the concatemer template molecule, wherein individual concatemer template molecules in the plurality are immobilized to a first surface primer that is immobilized to a support;
b) sequencing the plurality of immobilized concatemer template molecules with a plurality of soluble forward sequencing primers a plurality of sequencing polymerases, a plurality of multivalent molecules and a plurality of nucleotide analogs, thereby generating a plurality of extended forward sequencing primer strands, wherein individual immobilized concatemer template molecules have two or more extended forward sequencing primer strands hybridized thereon;
c) retaining the plurality of immobilized concatemer template molecules and replacing the plurality of extended forward sequencing primer strands with a plurality of forward extension strands that are hybridized to the retained immobilized single stranded nucleic acid concatemer template molecules by conducting a primer extension reaction;
d) removing the retained immobilized concatemer template molecules by generating abasic sites at the at least one uridine in the immobilized concatemer template molecules and generating gaps at the abasic sites to generate a plurality of gap-containing concatemer template molecules while retaining the plurality of forward extension strands and retaining the plurality of immobilized surface primers; and
e) sequencing the plurality of retained forward extension strands with a plurality of soluble reverse sequencing primers a plurality of sequencing polymerases, a plurality of multivalent molecules and a plurality of nucleotide analogs, thereby generating a plurality of extended reverse sequencing primer strands, wherein individual retained forward extension strands have two or more extended reverse sequencing primer strands hybridized thereon,
wherein individual multivalent molecules of the plurality of multivalent molecules of steps (b) and (e) comprise (1) a core; and (2) a plurality of nucleotide arms which comprise (i) a core attachment moiety, (ii) a spacer, (iii) a linker, and (iv) a nucleotide unit,
wherein the core is attached to the plurality of nucleotide arms via their core attachment moiety, and
wherein the spacer is attached to the linker, and wherein the linker is attached to the nucleotide unit.

2. The method of claim 1 , wherein the plurality of sequencing polymerases of steps (b) and (e) comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1316 and comprising amino acid substitutions aspartic acid at position 168 substituted with alanine (D168A) and glutamic acid at position 170 substituted with alanine (E170A).

3. The method of claim 1 , wherein individual concatemer template molecules in the plurality are covalently joined to an immobilized first surface primer.

4. The method of claim 1 , wherein individual concatemer template molecules in the plurality are hybridized to an immobilized first surface primer.

5. The method of claim 1 , wherein each nucleotide analog in the plurality of nucleotide analogs of steps (b) and (e) comprise a removable chain terminating moiety at the 3′ sugar group, wherein the removable chain terminating moiety comprises an alkyl group, alkenyl group, alkynyl group, allyl group, aryl group, benzyl group, azide group, azido group, O-azidomethyl group, amine group, amide group, keto group, isocyanate group, phosphate group, thio group, disulfide group, carbonate group, urea group, or silyl group, and wherein the removable chain terminating moiety is cleavable with a chemical compound to generate an extendible 3′ OH moiety on the sugar group.

6. The method of claim 1 , wherein the plurality of nucleotide analogs of steps (b) and (e) comprises one type of nucleotide selected from the group consisting of dATP, dGTP, dCTP, dTTP, and dUTP.

7. The method of claim 1 , wherein the plurality of nucleotide analogs of steps (b) and (C) comprises a mixture of any combination of two or more types of nucleotides selected from the group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

8. The method of claim 1 , wherein the plurality of nucleotide analogs of steps (b) and (e) comprises a plurality of non-labeled nucleotide analogs.

9. The method of claim 1 , wherein the plurality of nucleotide analogs of steps (b) and (e) comprises a plurality of at least one non-labeled nucleotide analog.

10. The method of claim 1 , wherein the plurality of nucleotide analogs of steps (b) and (e) comprises a plurality of fluorophore-labeled nucleotide analogs.

11. The method of claim 1 , wherein the plurality of nucleotide analogs of step (b) and (e) comprises 3-10 phosphate groups.

12. A method for pairwise sequencing, comprising:
a) providing a plurality of immobilized nucleic acid concatemer template molecules each comprising at least one uridine that can be enzymatically cleaved to generate an abasic site in the concatemer template molecule, wherein individual concatemer template molecules in the plurality are immobilized to a first surface primer that is immobilized to a support;
b) sequencing the plurality of immobilized concatemer template molecules with a plurality of soluble forward sequencing primers, a plurality of sequencing polymerases and a plurality of multivalent molecules and generating a plurality of extended forward sequencing primer strands, wherein individual immobilized concatemer template molecules have two or more extended forward sequencing primer strands hybridized thereon;
c) retaining the plurality of immobilized concatemer template molecules and replacing the plurality of extended forward sequencing primer strands with a plurality of forward extension strands that are hybridized to the retained immobilized single stranded nucleic acid concatemer template molecules by conducting a primer extension reaction;
d) removing the retained immobilized concatemer template molecules by generating abasic sites at the at least one uridine in the immobilized concatemer template molecules and generating gaps at the abasic sites to generate a plurality of gap-containing concatemer template molecules while retaining the plurality of forward extension strands and retaining the plurality of immobilized surface primers; and
e) sequencing the plurality of retained forward extension strands with a plurality of soluble reverse sequencing primers, a plurality of sequencing polymerases and a plurality of multivalent molecules, thereby generating a plurality of extended reverse sequencing primer strands, wherein individual retained forward extension strands have two or more extended reverse sequencing primer strands hybridized thereon,
wherein individual multivalent molecules of the plurality of multivalent molecules of steps (b) and (e) comprise (1) a core; and (2) a plurality of nucleotide arms which comprise (i) a core attachment moiety, (ii) a spacer, (iii) a linker, and (iv) a nucleotide unit,
wherein the core is attached to the plurality of nucleotide arms via their core attachment moiety, and
wherein the spacer is attached to the linker, and wherein the linker is attached to the nucleotide unit.

13. The method of claim 12 , wherein the plurality of sequencing polymerases of steps (b) and (e) comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1 and comprising amino acid substitutions aspartic acid at position 141 substituted with alanine (D141A) and glutamic

Assignees

• Element Biosciences Inc

Inventors

• Arslan Sinan
• Zhao Junhua
• He Molly
• Snow Samantha
• Light William
• Kellinger Matthew
• Previte Michael
• Kim Michael
• Yu Hua
• Hwang-Fu Yu-Hsien
• Tjioe Marco
• Boddicker Andrew
• Ambroso Mark
• Lopez Tyler
• Klein Michael
• Saade Virginia

Classifications

• C12Q1/6806 Primary

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q1/6834

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C12Q1/6853 Primary

  using modified primers or templates · CPC title

• C12Q1/6874

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• G01N21/6428

  Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title